title: HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen.
authors.forename: A
authors.initials: A
authors.lastname: Lafeuillade
authors.forename: C
authors.initials: C
authors.lastname: Solas
authors.forename: S
authors.initials: S
authors.lastname: Chadapaud
authors.forename: G
authors.initials: G
authors.lastname: Hittinger
authors.forename: C
authors.initials: C
authors.lastname: Poggi
authors.forename: B
authors.initials: B
authors.lastname: Lacarelle
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D005838:Genotype; D017320:HIV Protease Inhibitors / Q000032:analysis / Q000097:blood / Q000627:therapeutic use; D015497:HIV-1 / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D061466:Lopinavir; D008297:Male; D009154:Mutation; D011744:Pyrimidinones / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood*; D019438:Ritonavir / Q000627:therapeutic use; D012661:Semen / Q000737:chemistry*; D014018:Tissue Distribution
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D012367:RNA, Viral; D061466:Lopinavir; D019438:Ritonavir